J&J’s Stelara wins US nod for Crohn’s
US regulators have expanded the reach of Johnson & Johnson group Janssen Biologics' psoriasis blockbuster Stelara to include the treatment of patients with Crohn's disease.
27th September 2016
Latest news
GW Pharma’s cannabinoid hits targets in epilepsy trial
GW Pharmaceuticals has unveiled yet more positive data from a late-stage programme testing its cannabinoid Epidiolex in rare epilepsies, pushing its stock up more than 16 percent.
27th September 2016
Novartis bags three new approvals for Ilaris
Novartis has picked up three new indications for its anti-inflammatory Ilaris in the US, allowing its use to treat three rare and distinct types of Periodic Fever Syndromes.
27th September 2016
Junior doctors call off strike but contract fight goes on
The British Medical Association has called off further industrial action in protest over the new junior doctors contract on fears over patient safety.
27th September 2016
MSD, Wayra launch new digital accelerator programme
MSD and Wayra UK have unveiled the next focus of their digital health innovation accelerator programme, calling for "radical solutions" to improving the treatment and care of patients with diabetes and helping cancer patients self-manage recovery.
27th September 2016
GSK files for approval of subcutaneous lupus drug
GlaxoSmithKline has filed for approval of a subcutaneous formulation of its lupus drug Benlysta on both sides of the Atlantic.
26th September 2016
NICE clears Gilead’s pan-genotypic hep C drug Epclusa
The National Institute for Health and Care Excellence is endorsing Gilead's pan-genotypic hepatitis C drug Epclusa for routine NHS use in England and Wales.
26th September 2016
Latest SBRI comp offers £1.1m for GP innovations
NHS England investment fund SBRI Healthcare has launched its autumn competition offering entrepreneurs the opportunity for funding to drive forward their innovations within general practice.
26th September 2016
FDA approves the first Humira biosimilar
US regulators have issued a green light for the first biosimilar of AbbVie's biologic Humira, the world second best-selling drug.
26th September 2016
EU approves Truberzi for IBS-D
European regulators have issued a green light for Allergan's Truberzi, giving patients potential access to the first approved treatment for irritable bowel syndrome with diarrhoea (IBS-D).
23rd September 2016
Lundbeck reveals Alzheimer’s drug trial failure
Lundbeck has announced that the first late-stage trial of its experimental Alzheimer's disease candidate idalopirdine failed to hit its primary targets.
23rd September 2016
NHS England unveils funding plan for general practice
NHS England has published guidance confirming further local recurrent funding to improve and increase capacity in general practice.
23rd September 2016
Trial shows personalised medicine benefit in cancer patients
A clinical trial involving patients with advanced cancers is the first of its kind to show the benefit precision medicine can have on delaying tumour recurrence.
23rd September 2016
AstraZeneca pulls application for ovarian cancer drug
AstraZeneca is pulling back its application to market ovarian cancer drug cediranib in Europe, marking the end of the line for the drug's development in combination was chemotherapy.
22nd September 2016
Gilead pulls plug on ulcerative colitis drug
Gilead Sciences has pulled the plug on a combined Phase II/III clinical study of GS-5745 testing the investigational anti-MMP9 antibody in patients with moderately to severely active ulcerative colitis.
22nd September 2016
Latest jobs
View allMedical Sales Representative
Star Medical
£24000 - £28000 per annum
Primary Care Representative
Star Medical
Car, Pension, Life Assurance, Private Healthcare
Exciting New KAM Team Build - Cardiology - Kent & Medway
Highly Attractive Basic, Bonus and Benefits
Exciting New KAM Team Build - Cardiology - Lec/Beds/Luton/MK
Highly Attractive Basic, Bonus and Benefits
Exciting New KAM Team Build - Cardiology - Sheffield & Hull
Highly Attractive Basic, Bonus and Benefits
Exciting New KAM Team Build - Cardiology- Wessex, Bath, Swindon
Highly Attractive Basic, Bonus and Benefits
What job are you looking for?
Download our apps
Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.
Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.
